Cancer Test Market Report

Global and Region Cancer Test Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：173
  • REPORT CODE：GMM920570
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Cancer Test market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Cancer Testmarket, defines the market attractiveness level of Cancer Test market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Cancer Test industry, describes the types of Cancer Test market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cancer Test market and the development prospects and opportunities of Cancer Test industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cancer Test market in Chapter 13.

    By Player:

    • Vermillion

    • Radient Pharmaceuticals

    • Qiagen

    • Genomic Health

    • QIAGEN Marseille (Earlier Ipsogen)

    • Gen-Probe

    • Myriad Genetics

    • BD Diagnostics

    • Siemens Heathcare Diagnostics

    • Beckman Coulter

    • Ventana Medical Systems

    • bioMerieux

    • Abbott

    • CytoCore

    • BioCurex

    • Panacea Pharmaceuticals

    • Trovagene

    • DiagnoCure

    • Cepheid

    • Roche

    By Type:

    • Laboratory Tests

    • Genetic Tests

    • Imaging

    • Endoscopy

    By End-User:

    • Bladder Cancer Test

    • Breast Cancer Test

    • Cervical Cancer Test

    • Colorectal (Colon) Cancer Test

    • Ovarian Cancer Test

    • Prostate Cancer Test

    • Liver Cancer Test

    • Flow Cytometry

    • Other Organ Specific Cancer Test

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Cancer Test Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Cancer Test Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Cancer Test Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Cancer Test Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Cancer Test Market Analysis and Outlook to 2022

    • 7.1 Global Cancer Test Consumption (2017-2022)

    • 7.2 United States Cancer Test Consumption (2017-2022)

    • 7.3 Europe Cancer Test Consumption (2017-2022)

    • 7.4 China Cancer Test Consumption (2017-2022)

    • 7.5 Japan Cancer Test Consumption (2017-2022)

    • 7.6 India Cancer Test Consumption (2017-2022)

    • 7.7 South Korea Cancer Test Consumption (2017-2022)

    8 Region and Country-wise Cancer Test Market Analysis and Outlook to 2028

    • 8.1 Global Cancer Test Consumption Forecast (2022-2028)

    • 8.2 United States Cancer Test Consumption Forecast (2022-2028)

    • 8.3 Europe Cancer Test Consumption Forecast (2022-2028)

    • 8.4 China Cancer Test Consumption Forecast (2022-2028)

    • 8.5 Japan Cancer Test Consumption Forecast (2022-2028)

    • 8.6 India Cancer Test Consumption Forecast (2022-2028)

    • 8.7 South Korea Cancer Test Consumption Forecast (2022-2028)

    9 Global Cancer Test Market Outlook by Types and Applications to 2022

    • 9.1 Global Cancer Test Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Laboratory Tests Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Genetic Tests Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Imaging Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Endoscopy Consumption and Growth Rate (2017-2022)

    • 9.2 Global Cancer Test Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Bladder Cancer Test Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Breast Cancer Test Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Cervical Cancer Test Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Colorectal (Colon) Cancer Test Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Ovarian Cancer Test Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Prostate Cancer Test Consumption and Growth Rate (2017-2022)

      • 9.2.7 Global Liver Cancer Test Consumption and Growth Rate (2017-2022)

      • 9.2.8 Global Flow Cytometry Consumption and Growth Rate (2017-2022)

      • 9.2.9 Global Other Organ Specific Cancer Test Consumption and Growth Rate (2017-2022)

    10 Global Cancer Test Market Outlook by Types and Applications to 2028

    • 10.1 Global Cancer Test Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Laboratory Tests Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Genetic Tests Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Imaging Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Endoscopy Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Cancer Test Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Bladder Cancer Test Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Breast Cancer Test Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Cervical Cancer Test Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Colorectal (Colon) Cancer Test Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Ovarian Cancer Test Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.6 Global Prostate Cancer Test Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.7 Global Liver Cancer Test Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.8 Global Flow Cytometry Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.9 Global Other Organ Specific Cancer Test Consumption Forecast and Growth Rate (2022-2028)

    11 Global Cancer Test Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Cancer Test Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Cancer Test Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Cancer Test Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Cancer Test Market Competitive Analysis

    • 14.1 Vermillion

      • 14.1.1 Vermillion Company Details

      • 14.1.2 Vermillion Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Vermillion Cancer Test Product and Service

    • 14.2 Radient Pharmaceuticals

      • 14.2.1 Radient Pharmaceuticals Company Details

      • 14.2.2 Radient Pharmaceuticals Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Radient Pharmaceuticals Cancer Test Product and Service

    • 14.3 Qiagen

      • 14.3.1 Qiagen Company Details

      • 14.3.2 Qiagen Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Qiagen Cancer Test Product and Service

    • 14.4 Genomic Health

      • 14.4.1 Genomic Health Company Details

      • 14.4.2 Genomic Health Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Genomic Health Cancer Test Product and Service

    • 14.5 QIAGEN Marseille (Earlier Ipsogen)

      • 14.5.1 QIAGEN Marseille (Earlier Ipsogen) Company Details

      • 14.5.2 QIAGEN Marseille (Earlier Ipsogen) Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 QIAGEN Marseille (Earlier Ipsogen) Cancer Test Product and Service

    • 14.6 Gen-Probe

      • 14.6.1 Gen-Probe Company Details

      • 14.6.2 Gen-Probe Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Gen-Probe Cancer Test Product and Service

    • 14.7 Myriad Genetics

      • 14.7.1 Myriad Genetics Company Details

      • 14.7.2 Myriad Genetics Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Myriad Genetics Cancer Test Product and Service

    • 14.8 BD Diagnostics

      • 14.8.1 BD Diagnostics Company Details

      • 14.8.2 BD Diagnostics Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 BD Diagnostics Cancer Test Product and Service

    • 14.9 Siemens Heathcare Diagnostics

      • 14.9.1 Siemens Heathcare Diagnostics Company Details

      • 14.9.2 Siemens Heathcare Diagnostics Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Siemens Heathcare Diagnostics Cancer Test Product and Service

    • 14.10 Beckman Coulter

      • 14.10.1 Beckman Coulter Company Details

      • 14.10.2 Beckman Coulter Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Beckman Coulter Cancer Test Product and Service

    • 14.11 Ventana Medical Systems

      • 14.11.1 Ventana Medical Systems Company Details

      • 14.11.2 Ventana Medical Systems Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Ventana Medical Systems Cancer Test Product and Service

    • 14.12 bioMerieux

      • 14.12.1 bioMerieux Company Details

      • 14.12.2 bioMerieux Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 bioMerieux Cancer Test Product and Service

    • 14.13 Abbott

      • 14.13.1 Abbott Company Details

      • 14.13.2 Abbott Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Abbott Cancer Test Product and Service

    • 14.14 CytoCore

      • 14.14.1 CytoCore Company Details

      • 14.14.2 CytoCore Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 CytoCore Cancer Test Product and Service

    • 14.15 BioCurex

      • 14.15.1 BioCurex Company Details

      • 14.15.2 BioCurex Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 BioCurex Cancer Test Product and Service

    • 14.16 Panacea Pharmaceuticals

      • 14.16.1 Panacea Pharmaceuticals Company Details

      • 14.16.2 Panacea Pharmaceuticals Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Panacea Pharmaceuticals Cancer Test Product and Service

    • 14.17 Trovagene

      • 14.17.1 Trovagene Company Details

      • 14.17.2 Trovagene Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Trovagene Cancer Test Product and Service

    • 14.18 DiagnoCure

      • 14.18.1 DiagnoCure Company Details

      • 14.18.2 DiagnoCure Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 DiagnoCure Cancer Test Product and Service

    • 14.19 Cepheid

      • 14.19.1 Cepheid Company Details

      • 14.19.2 Cepheid Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Cepheid Cancer Test Product and Service

    • 14.20 Roche

      • 14.20.1 Roche Company Details

      • 14.20.2 Roche Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Roche Cancer Test Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Cancer Test

    • Figure Cancer Test Picture

    • Table Global Cancer Test Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Cancer Test Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Cancer Test Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Cancer Test Consumption by Country (2017-2022)

    • Figure United States Cancer Test Consumption and Growth Rate (2017-2022)

    • Table Europe Cancer Test Consumption and Growth Rate (2017-2022)

    • Figure China Cancer Test Consumption and Growth Rate (2017-2022)

    • Figure Japan Cancer Test Consumption and Growth Rate (2017-2022)

    • Figure India Cancer Test Consumption and Growth Rate (2017-2022)

    • Figure South Korea Cancer Test Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Test Consumption Forecast by Country (2022-2028)

    • Figure United States Cancer Test Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Cancer Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Cancer Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Cancer Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Cancer Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Cancer Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Laboratory Tests Consumption and Growth Rate (2017-2022)

    • Figure Global Genetic Tests Consumption and Growth Rate (2017-2022)

    • Figure Global Imaging Consumption and Growth Rate (2017-2022)

    • Figure Global Endoscopy Consumption and Growth Rate (2017-2022)

    • Figure Global Bladder Cancer Test Consumption and Growth Rate (2017-2022)

    • Figure Global Breast Cancer Test Consumption and Growth Rate (2017-2022)

    • Figure Global Cervical Cancer Test Consumption and Growth Rate (2017-2022)

    • Figure Global Colorectal (Colon) Cancer Test Consumption and Growth Rate (2017-2022)

    • Figure Global Ovarian Cancer Test Consumption and Growth Rate (2017-2022)

    • Figure Global Prostate Cancer Test Consumption and Growth Rate (2017-2022)

    • Figure Global Liver Cancer Test Consumption and Growth Rate (2017-2022)

    • Figure Global Flow Cytometry Consumption and Growth Rate (2017-2022)

    • Figure Global Other Organ Specific Cancer Test Consumption and Growth Rate (2017-2022)

    • Figure Global Laboratory Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Genetic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Imaging Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Endoscopy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Bladder Cancer Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Breast Cancer Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cervical Cancer Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Colorectal (Colon) Cancer Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ovarian Cancer Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prostate Cancer Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Liver Cancer Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Flow Cytometry Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Organ Specific Cancer Test Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Cancer Test Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Cancer Test Export by Region (Top 5 Countries) (2017-2028)

    • Table Vermillion (Foundation Year, Company Profile and etc.)

    • Table Vermillion Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Vermillion Cancer Test Product and Service

    • Table Radient Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Radient Pharmaceuticals Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Radient Pharmaceuticals Cancer Test Product and Service

    • Table Qiagen (Foundation Year, Company Profile and etc.)

    • Table Qiagen Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Qiagen Cancer Test Product and Service

    • Table Genomic Health (Foundation Year, Company Profile and etc.)

    • Table Genomic Health Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genomic Health Cancer Test Product and Service

    • Table QIAGEN Marseille (Earlier Ipsogen) (Foundation Year, Company Profile and etc.)

    • Table QIAGEN Marseille (Earlier Ipsogen) Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table QIAGEN Marseille (Earlier Ipsogen) Cancer Test Product and Service

    • Table Gen-Probe (Foundation Year, Company Profile and etc.)

    • Table Gen-Probe Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gen-Probe Cancer Test Product and Service

    • Table Myriad Genetics (Foundation Year, Company Profile and etc.)

    • Table Myriad Genetics Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Myriad Genetics Cancer Test Product and Service

    • Table BD Diagnostics (Foundation Year, Company Profile and etc.)

    • Table BD Diagnostics Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table BD Diagnostics Cancer Test Product and Service

    • Table Siemens Heathcare Diagnostics (Foundation Year, Company Profile and etc.)

    • Table Siemens Heathcare Diagnostics Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Siemens Heathcare Diagnostics Cancer Test Product and Service

    • Table Beckman Coulter (Foundation Year, Company Profile and etc.)

    • Table Beckman Coulter Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Beckman Coulter Cancer Test Product and Service

    • Table Ventana Medical Systems (Foundation Year, Company Profile and etc.)

    • Table Ventana Medical Systems Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ventana Medical Systems Cancer Test Product and Service

    • Table bioMerieux (Foundation Year, Company Profile and etc.)

    • Table bioMerieux Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table bioMerieux Cancer Test Product and Service

    • Table Abbott (Foundation Year, Company Profile and etc.)

    • Table Abbott Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Cancer Test Product and Service

    • Table CytoCore (Foundation Year, Company Profile and etc.)

    • Table CytoCore Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table CytoCore Cancer Test Product and Service

    • Table BioCurex (Foundation Year, Company Profile and etc.)

    • Table BioCurex Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioCurex Cancer Test Product and Service

    • Table Panacea Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Panacea Pharmaceuticals Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Panacea Pharmaceuticals Cancer Test Product and Service

    • Table Trovagene (Foundation Year, Company Profile and etc.)

    • Table Trovagene Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Trovagene Cancer Test Product and Service

    • Table DiagnoCure (Foundation Year, Company Profile and etc.)

    • Table DiagnoCure Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table DiagnoCure Cancer Test Product and Service

    • Table Cepheid (Foundation Year, Company Profile and etc.)

    • Table Cepheid Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cepheid Cancer Test Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Cancer Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Cancer Test Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US